|
Linda,
I am really sad to hear this. This disease has thrown a lot at you guys, and it doesn't seem to be done yet.
I suppose the next question will be whether, at this point, to call it AML, and whether to treat it with induction chemotherapy or with something else.
I'm sorry the promacta trial didn't work out, but we are all still pulling for you.
Take care!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|